| Year |
Citation |
Score |
| 2025 |
Xu G, Havens CG, Deng Q, Lowenstein C, Samanta D, Vidal B, Behshad E, Russell M, Orth P, Rice CT, Nagilla R, Kirchhoff P, Chen Z, Rej RK, Acharyya RK, et al. Discovery and Characterization of PVTX-321 as a Potent and Orally Bioavailable Estrogen Receptor Degrader for ER+/HER2- Breast Cancer. Journal of Medicinal Chemistry. PMID 40366756 DOI: 10.1021/acs.jmedchem.5c00223 |
0.745 |
|
| 2025 |
Acharyya RK, Rej RK, Hu B, Chen Z, Wu D, Lu J, Metwally H, McEachern D, Wang Y, Jiang W, Bai L, Tošović J, Gersch CL, Xu G, Zhang W, et al. Correction to "Discovery of ERD-1233 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader for the Treatment of ER+ Human Breast Cancer". Journal of Medicinal Chemistry. PMID 40198894 DOI: 10.1021/acs.jmedchem.5c00592 |
0.735 |
|
| 2024 |
Rej RK, Hu B, Chen Z, Acharyya RK, Wu D, Metwally H, McEachern D, Wang Y, Jiang W, Bai L, Nishimura LS, Gersch CL, Wang M, Wen B, Sun D, et al. Discovery of ERD-12310A as an Exceptionally Potent and Orally Efficacious PROTAC Degrader of Estrogen Receptor α (ERα). Journal of Medicinal Chemistry. PMID 39585895 DOI: 10.1021/acs.jmedchem.4c01401 |
0.732 |
|
| 2024 |
Acharyya RK, Rej RK, Hu B, Chen Z, Wu D, Lu J, Metwally H, McEachern D, Wang Y, Jiang W, Bai L, Tošović J, Gersch CL, Xu G, Zhang W, et al. Discovery of ERD-1233 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader for the Treatment of ER+ Human Breast Cancer. Journal of Medicinal Chemistry. PMID 39485242 DOI: 10.1021/acs.jmedchem.4c01521 |
0.744 |
|
| 2024 |
Rej RK, Allu SR, Roy J, Acharyya RK, Kiran INC, Addepalli Y, Dhamodharan V. Orally Bioavailable Proteolysis-Targeting Chimeras: An Innovative Approach in the Golden Era of Discovering Small-Molecule Cancer Drugs. Pharmaceuticals (Basel, Switzerland). 17. PMID 38675453 DOI: 10.3390/ph17040494 |
0.716 |
|
| 2024 |
Rej RK, Roy J, Allu SR. Therapies for the Treatment of Advanced/Metastatic Estrogen Receptor-Positive Breast Cancer: Current Situation and Future Directions. Cancers. 16. PMID 38339303 DOI: 10.3390/cancers16030552 |
0.302 |
|
| 2023 |
Chen Z, Hu B, Rej RK, Wu D, Acharyya RK, Wang M, Xu T, Lu J, Metwally H, Wang Y, McEachern D, Bai L, Gersch CL, Wang M, Zhang W, et al. Discovery of as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader with Strong Antitumor Activity. Journal of Medicinal Chemistry. PMID 37647546 DOI: 10.1021/acs.jmedchem.3c01186 |
0.743 |
|
| 2023 |
Rej RK, Thomas JE, Acharyya RK, Rae JM, Wang S. Targeting the Estrogen Receptor for the Treatment of Breast Cancer: Recent Advances and Challenges. Journal of Medicinal Chemistry. PMID 37377342 DOI: 10.1021/acs.jmedchem.3c00136 |
0.743 |
|
| 2018 |
Acharyya RK, Rej RK, Nanda S. Exploration of Ring Rearrangement Metathesis Reaction: A General and Flexible Approach for the Rapid Construction [5,n]-Fused Bicyclic Systems en Route to Linear Triquinanes. The Journal of Organic Chemistry. 83: 2087-2103. PMID 29308638 DOI: 10.1021/Acs.Joc.7B03021 |
0.731 |
|
| 2016 |
Kumar R, Rej RK, Halder J, Mandal H, Nanda S. Enantiopure hydroxymethylated cycloalkenols as privileged small molecular multifunctional scaffolds for the asymmetric synthesis of carbocycles Tetrahedron Asymmetry. 27: 498-512. DOI: 10.1016/J.Tetasy.2016.05.003 |
0.746 |
|
| 2016 |
Rej RK, Acharyya RK, Nanda S. Asymmetric synthesis of dihydroartemisinic acid through intramolecular Stetter reaction Tetrahedron. 72: 4931-4937. DOI: 10.1016/J.Tet.2016.06.066 |
0.745 |
|
| 2015 |
Kumar R, Rej RK, Nanda S. Asymmetric total synthesis of (−)-mangiferaelactone by using an appropriately substituted thiophene as a masked synthon for C-alkyl glycoside Tetrahedron: Asymmetry. 26: 751-759. DOI: 10.1016/J.Tetasy.2015.06.001 |
0.674 |
|
| 2015 |
Rej RK, Kumar R, Nanda S. Asymmetric synthesis of cytospolides C and D through successful exploration of stereoselective Julia–Kocienski olefination and Suzuki reaction followed by macrolactonization Tetrahedron. 71: 3185-3194. DOI: 10.1016/J.Tet.2015.04.014 |
0.665 |
|
| 2014 |
Rej RK, Pal P, Nanda S. Asymmetric synthesis of naturally occurring (−)-seimatopolides A and B Tetrahedron. 70: 4457-4470. DOI: 10.1016/J.Tet.2014.05.021 |
0.717 |
|
| 2014 |
Rej RK, Jana A, Nanda S. Asymmetric synthesis of naturally occurring nonenolide xyolide through cross metathesis and macrolactonization reaction Tetrahedron. 70: 2634-2642. DOI: 10.1016/J.Tet.2014.02.072 |
0.669 |
|
| 2014 |
Rej RK, Pal P, Nanda S. ChemInform Abstract: Asymmetric Synthesis of Naturally Occurring (-)-Seimatopolides A (I) and B (II). Cheminform. 45: no-no. DOI: 10.1002/CHIN.201450204 |
0.685 |
|
| 2014 |
Rej RK, Nanda S. ChemInform Abstract: Chemoenzymatic Asymmetric Total Synthesis of Nonanolide (Z)-Cytospolides D (I), E (II) and Their Stereoisomers. Cheminform. 45: no-no. DOI: 10.1002/CHIN.201443218 |
0.575 |
|
| 2014 |
Rej RK, Jana A, Nanda S. ChemInform Abstract: Asymmetric Synthesis of Naturally Occurring Nonenolide Xyolide Through Cross Metathesis and Macrolactonization Reaction. Cheminform. 45: no-no. DOI: 10.1002/CHIN.201435219 |
0.63 |
|
| 2013 |
Rej RK, Das T, Hazra S, Nanda S. Chemoenzymatic asymmetric synthesis of fluoxetine, atomoxetine, nisoxetine, and duloxetine Tetrahedron Asymmetry. 24: 913-918. DOI: 10.1016/J.Tetasy.2013.06.003 |
0.7 |
|
| 2013 |
Rej RK, Nanda S. Chemoenzymatic Asymmetric Total Synthesis of Nonanolide (Z)-Cytospolides D, E and Their Stereoisomers European Journal of Organic Chemistry. 2014: 860-871. DOI: 10.1002/Ejoc.201301365 |
0.654 |
|
| 2012 |
Rej R, Jana N, Kar S, Nanda S. Stereoselective synthesis of a novel natural carbasugar and analogues from hydroxymethylated cycloalkenone scaffolds Tetrahedron: Asymmetry. 23: 364-372. DOI: 10.1016/J.Tetasy.2012.03.001 |
0.661 |
|
| Show low-probability matches. |